Free Trial

Amgen's $24B 8Pt Debt Deal Seventh Largest on Record

PIPELINE

$30B total priced Wednesday, thanks to Amgen's $24B 8pt "mega" issuance to help finance it's $28B acquisition of Horizon Pharmaceuticals. Amgen issuance the seventh largest bond issuance on record, topping $22B Cigna offering in 2018.

  • Date $MM Issuer (Priced *, Launch #)
  • 02/15 $24B *Amgen $2B 2Y +65, $1.5B 3NC1 +115, $3.75B 5Y +115, $2.75B 7Y +135, $4.25B 10Y +150, $2.75B 20Y +165, $4.25B 30Y +185, $2.75B 40Y +200
  • 02/15 $5B *MUFG $1.65B 3NC2 +108, $600M 3NC2 SOFR+94, $1B 6NC5 +138, $500M 8NC7 +153, $1.25B 11NC10 +163
  • 02/15 $1B *Gov of Sharjah +9Y +280
    • Record Issuance Holders:
    • 8/11/13 $49B Verizon
    • 1/13/16 $46B AB InBev
    • 9/04/18 $40B CVS over 9 tranches
    • 11/12/19 $30B AbbVie jumbo 10-part
    • 3/9/2022 $30B ATT/Discovery 11pt via Magallanes inc
    • 4/30/20 $25B Boeing 7pt

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.